MedPath
NMPA Approval

Valsartan and Amlodipine Tablets(I)

国药准字H20243509

April 17, 2024

Drug Information

缬沙坦氨氯地平片(Ⅰ)

片剂

每片含缬沙坦80mg、氨氯地平5mg

化学药品

April 17, 2024

Company Information

Applicant Company

天津新技术产业园区武清开发区泉发路西

Manufacturing Company

天津新技术产业园区武清开发区泉发路西

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.